Cargando…
Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies
There is a growing need to better understand the risk of malignancy in the multiple sclerosis (MS) population, particularly given the relatively recent and widespread introduction of immunomodulating disease modifying therapies (DMTs). Multiple sclerosis disproportionately affects women, and the ris...
Autores principales: | Bridge, Francesca, Brotherton, Julia M. L., Foong, Yi, Butzkueven, Helmut, Jokubaitis, Vilija G., Van der Walt, Anneke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950275/ https://www.ncbi.nlm.nih.gov/pubmed/36846149 http://dx.doi.org/10.3389/fneur.2023.1119660 |
Ejemplares similares
-
Increased risk of cervical dysplasia in females with autoimmune conditions—Results from an Australia database linkage study
por: Foster, Emma, et al.
Publicado: (2020) -
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023) -
The MSBase pregnancy, neonatal outcomes, and women’s health registry
por: Jokubaitis, Vilija G., et al.
Publicado: (2021) -
The feasibility, reliability and concurrent validity of the MSReactor
computerized cognitive screening tool in multiple sclerosis
por: Merlo, Daniel, et al.
Publicado: (2019) -
Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
por: Hillert, Jan, et al.
Publicado: (2021)